Molecular Imaging: Page 49

New PET radiotracer shows promise for rare brain disorder diagnosis

By Will Morton

PET imaging with an experimental radiotracer called F-18 Florzolotau shows promise for the diagnosis of early progressive supranuclear palsy, a team of researchers has found.

January 17, 2023

Evidence supports surveillance imaging in patients with HNC

By Will Morton

In one of the only large-scale studies on the issue, researchers have shown that surveillance imaging in patients with head and neck cancer (HNC) saves lives, according to a study published online January 10 in Radiology.

January 12, 2023

MRI, PET boost central nervous system disease treatment discovery

By Kate Madden Yee

Neuroimaging modalities such as MRI, PET, and SPECT have key roles to play in clinical trials that explore the diagnosis and treatment of central nervous system (CNS) diseases like Alzheimer's, Parkinson's, depression, and schizophrenia, according to a paper published January 6 in Drug Discovery Today.

January 11, 2023

NorthStar produces first Mo-99 batch at new facility

By AuntMinnie.com staff writers

NorthStar Medical Isotopes has produced the first batch of molybdenum-99 (Mo-99) at its recently completed therapeutic radioisotope production facility in Beloit, WI.

January 10, 2023

Brain PET imaging reveals role of serotonin in Alzheimer's disease

By Will Morton

PET imaging has shown a link between serotonin brain activity in early Alzheimer's disease patients to beta-amyloid plaque deposits, a hallmark of the condition, according to a study published online on January 6 in NeuroImage: Clinical.

January 10, 2023

PET tracer may improve prostate cancer imaging

By Will Morton

PET/CT imaging with an experimental F-18 prostate-specific membrane antigen radiotracer improves the care of patients with recurrent prostate cancer, according to a study published on January 7 in Research in Diagnostic and Interventional Imaging.

January 9, 2023

AI model predicts cancer aggressiveness on PET

By Will Morton

A machine-learning model based on PET imaging features shows promise for helping clinicians assess the aggressiveness of endometrial cancer prior to surgery, according to a study published online January 4 in Cancers.

January 9, 2023

Brain PET/MRI scans reveal visual snow syndrome

By Will Morton

PET/MRI scans have revealed significant structural and metabolic brain abnormalities in patients with visual snow syndrome, according to a study published December 30 in EJNMMI Research.

January 8, 2023

FDA approves new drug for Alzheimer's disease

By Will Morton

Japanese drug developer Eisai has received U.S. Food and Drug Administration (FDA) approval for its Leqembi (lecanemab) treatment for individuals with Alzheimer's disease. The drug is the second of a new category of medications for the disease to go through the FDA's accelerated regulatory pathway.

January 5, 2023

PSMA-PET shows value in primary staging of prostate cancer

By Will Morton

Prostate-specific membrane antigen (PSMA) PET/CT imaging can reveal metastatic bone cancer lesions in prostate cancer patients that may be undetected by conventional bone scintigraphy, according to a group in the Netherlands.

January 5, 2023

FAPI-PET shows promise over conventional PET for identifying cancer

By Will Morton

Gallium-68 fibroblast activation protein inhibitor (FAPI) PET imaging may improve tumor detection in cancer patients over conventional imaging, according to a study published December 30 in the Journal of Nuclear Medicine.

January 4, 2023

NorthStar and Inhibrx ink deal on radiopharmaceutical development

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and biopharmaceutical company Inhibrx have inked a collaboration agreement for the development and production of new radiopharmaceuticals.

January 3, 2023

Previous Page

Page 49 of 612

Next Page